Lactoferrin - Metrodora Therapeutics

Drug Profile

Lactoferrin - Metrodora Therapeutics

Alternative Names: Bovine lactoferrin - Metrodora Therapeutics

Latest Information Update: 15 Aug 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Metrodora Therapeutics
  • Class Adjuvants; Anti-inflammatories; Antibacterials; Antifungals; Glycoproteins; Iron binding proteins; Proteins
  • Mechanism of Action Chelating agents; Immunomodulators
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Enterocolitis; Sepsis
  • New Molecular Entity No

Highest Development Phases

  • Phase I Crohn's disease

Most Recent Events

  • 07 Aug 2017 Phase-I clinical trials in Crohn's disease (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top